Skip to content

Clinical trials

Phase 3 Pathologic Processes trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pathologic Processes Phase: Phase 3 Country / region: United States Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20094
20111
20121
20141
20161
20172
20181
20202
20211
20233
20251
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Active, not recruiting6
Recruiting3
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bausch Health Americas, Inc.3
Taysha Gene Therapies, Inc.2
University of Colorado, Denver2
Vertex Pharmaceuticals Incorporated2
Zealand Pharma2
AstraZeneca1
Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)1
Eli Lilly and Company1
Grifols Therapeutics LLC1
Mundipharma Research Limited1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pathologic Processes21
Digestive System Diseases7
Gastrointestinal Diseases6
Intestinal Diseases6
Lung Diseases5
Respiratory Tract Diseases5
Colitis4
Colitis, Ulcerative4
Colonic Diseases4
Gastroenteritis4

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.